Drug Profile
HS 058
Latest Information Update: 30 May 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections; Measles; Parainfluenza virus infections; Respiratory syncytial virus infections
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 02 Sep 1998 No-Development-Reported for Influenza virus infections in Japan (Unknown route)
- 02 Sep 1998 No-Development-Reported for Influenza virus infections in USA (Unknown route)